The FDA is expanding the warning about the risk of toxic exposures from Fresenius hemodialysis machines to include other manufacturer's devices and peritoneal dialysis systems.
The FDA has sent a letter to healthcare professionals warning of toxic compounds and potential adverse health effects linked to some Fresenius hemodialysis machines.
A Fresenius Volumat infusion pump recall comes after one death and reports of software errors.
A federal jury in Denver has ordered DaVita, the dialysis center chain, to pay $383.5 million to the families of three patients who died after being given GranuFlo during dialysis…
The first trial over claims that Fresenius failed to warn patients of potential cardiac arrest linked to its GranuFlo and NaturaLyte dialysis products has resulted in a defense verdict.
2016 was marked by a number of huge verdicts in crucial bellwether lawsuits and large settlement agreements over product liability claims that caused consumers to suffer severe injuries, health problems…
Kentucky has filed a lawsuit against Fresenius for promoting its GranuFlo dialysate product without warning about the risk of cardiac arrest.
A $250 million settlement agreement has been put forward by Fresenius, the makers of GranuFlo and NaturaLyte dialysis products linked to cardiac arrest.
Two Fresenius dialysis bellwether cases are being prepared for the first federal trials over the recalled drugs early next year, which could set the tone for thousands of cases to…
Fresenius has recalled more than 1.8 million bottles of NaturaLyte due to the risk of bacterial contamination, which may pose serious risks for dialysis patients.
